Add BrightSurf on Google Email

New biomarker interaction may help predict breast cancer metastasis and identify patients most likely to benefit from treatment

A new study identified a previously underappreciated relationship between SUCLA2 and USP10 that strongly correlates with distant metastasis-free survival in breast cancer patients. The interaction between these two genes changes dramatically depending on whether patients receive treatment, highlighting the importance of considering mol...

SourceScience Exploration Press·JournalComputational Biomedicine·TypeData/statistical analysis·DateAug 7, 2026

AirPods-sized fluorescence analytical device holds the promise for timely home molecular testing

A portable, airpod-size fluorescence analytical device has been designed to provide timely home molecular testing. The VPodDuo can measure fluorescent signals generated by various detection chemistry formats and detect quantities of genetic material from several pathogens and human cancer markers.

ECOG-ACRIN ENDURANCE trial findings published in the New England Journal of Medicine provide the first randomized evidence on the optimal duration of lenalidomide maintenance for patients with newly diagnosed multiple myeloma

The ECOG-ACRIN ENDURANCE trial found that indefinite lenalidomide maintenance had no survival benefit and more toxicity compared to stopping treatment after 2 years in patients not undergoing a stem cell transplant. The study suggests that fixed duration treatment can significantly reduce healthcare costs.

SourceECOG-ACRIN Cancer Research Group·JournalNew England Journal of Medicine·DateJul 15, 2026

ADLM 2026 to explore diabetes milestones, space diagnostics, Alzheimer’s and Down syndrome linkages, and advances in cancer screening and biomarkers

The meeting will explore breakthroughs in diabetes prevention and treatment, as well as innovative approaches to monitoring astronauts' health in space. Researchers will also discuss potential targets for slowing or preventing Alzheimer's disease in people with Down syndrome, and advancements in cervical cancer screening.

New algorithm improves gene expression marker identification across diverse biological systems

Researchers developed a new computational approach to identify genes that characterize different cellular states from mRNA-seq data, offering more accurate and interpretable analysis of complex biological data. The Cartesian Distance-Based Gene Expression (CDBGE) algorithm was evaluated using multiple publicly available datasets, demon...

SourceGermans Trias i Pujol Research Institute·JournalFrontiers in Immunology·TypeData/statistical analysis·DateJul 15, 2026

Macrophages take center stage in organ transplantation: from chronic rejection mechanisms to targeted therapies

Macrophages are critical drivers of chronic allograft failure, with emerging strategies targeting key macrophage signaling pathways providing an important conceptual shift. Targeted therapies, such as inhibiting the purinergic pathway and mTOR/NF-κB pathway, show promise in preventing chronic rejection.

SourceImmunity & Inflammation·JournalImmunity & Inflammation·TypeSystematic review·DateJul 9, 2026

Tuberculosis vaccine changes brain’s immune environment and Alzheimer’s biomarkers in older adults

A new study found that BCG vaccines can modify Alzheimer's biomarkers in non-Alzheimer's participants, suggesting a potential biological explanation for the observed link between BCG vaccination and lower disease risk. The vaccine also promoted increased immune responses in healthy participants without Alzheimer's pathology.

SourceMass General Brigham·JournalCommunications Medicine·TypeRandomized controlled/clinical trial·DateJul 6, 2026

B-cell lymphoma: Cause of high-risk disease discovered

A new study has identified molecular tumor characteristics that distinguish between different subtypes of diffuse large B-cell lymphoma (DLBCL). The findings suggest that tumors from high-risk patients, referred to as PG4 proteogenotype, are characterized by specific genetic mutations and protein patterns. These characteristics can hel...

SourceGoethe University Frankfurt·JournalCancer Cell·TypeExperimental study·DateJul 3, 2026

Alzheimer’s disease biomarkers can also predict cognitive decline in people over 80

A study reveals that Alzheimer's disease biomarkers are associated with rapid cognitive decline and progression to dementia in people over 80. The presence of these biomarkers identifies patients at risk of more significant impairment and loss of independence, even within the context of multiple coexisting conditions.

SourceInstitut de Recerca Sant Pau (Sant Pau Research Institute)·JournalNeurology·TypeObservational study·DateJul 1, 2026

Moving toward better tests and treatments for Lyme disease

Researchers at Tufts University School of Medicine discovered biomarkers that could help clinicians better detect and possibly cure early and persistent Borrelia burgdorferi infections. Anti-lipid antibodies, such as anti-phosphatidic acid and anti-phosphatylserine, may indicate new Lyme disease infections or persistent symptoms after ...

SourceTufts University·JournalInfection and Immunity·TypeData/statistical analysis·DateJun 30, 2026

Single-cell sequencing offers a roadmap from exercise tissue responses to precision exercise biomarkers

Single-cell sequencing resolves responses in various tissues and organs, identifying cells that respond to different exercise modes and doses. This technology enables the development of precision exercise biomarkers for applications in muscle repair, immune regulation, and chronic disease research.

SourceShanghai Jiao Tong University Journal Center·JournalLabMed Discovery·TypeNews article·DateJun 26, 2026

Investigators identify blood protein signature for non-invasive diagnosis of pediatric inflammatory bowel disease

A team of researchers has identified a distinct blood protein pattern that can accurately diagnose pediatric inflammatory bowel disease and differentiate between its two main forms. The discovery, using proteomics technology, showed high accuracy in identifying IBD and distinguishing ulcerative colitis from Crohn's disease.

SourceMass General Brigham·JournalEBioMedicine·TypeSystematic review·DateJun 23, 2026

'A cautionary tale': Study challenges assumption about brain activity in movement disorders

A new study by Meike van der Heijden challenges the long-held assumption that activity in easily measured cerebellar cells like Purkinje cells can reliably predict signals in deeper brain regions linked to dystonia, ataxia, and tremor. The research found no significant correlation between Purkinje cell and deep nuclei cell activity.

SourceVirginia Tech·JournalThe Journal of Physiology·TypeData/statistical analysis·DateJun 22, 2026

Radiation therapy enhances immune environment in brain metastases, improving treatment response

Researchers found that radiation therapy not only targets tumor cells but also activates immune pathways to make tumors more receptive to immunotherapy. The study suggests that radiation-immunotherapy combination strategies could improve patient outcomes by reshaping the surrounding immune landscape and recruiting T cells.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalClinical Cancer Research·DateJun 17, 2026

Antibody clues could improve long COVID care and prognosis

A study by Okayama University researchers revealed that SARS-CoV-2 antibody levels can assess infection history, symptom severity, and cognitive complications in long COVID. The findings suggest that declining S-antibody levels may indicate a greater risk of neurological complications.

SourceOkayama University·JournalBritish Journal of Biomedical Science·TypeObservational study·DateJun 12, 2026

Louse-borne relapsing fever: How the pathogen evades the immune system

Researchers identified five immunomodulatory proteins in Borrelia recurrentis that prevent activation of the human complement system, allowing the pathogen to survive in the human body. These Chi proteins also convert plasminogen into active plasmin, giving Borrelia recurrentis a significant advantage in spreading after infection.

SourceGoethe University Frankfurt·JournalNature Communications·TypeExperimental study·DateJun 10, 2026

Single-cell characterization of peripheral immune dysregulation in systemic juvenile idiopathic arthritis

A study characterizes peripheral immune alterations in systemic juvenile idiopathic arthritis, identifying a distinct CD14+CXCL10+ monocyte subpopulation associated with inflammatory network remodeling and disease activity. The monocyte subset is enriched in active sJIA states and exists in a heightened state of immune surveillance.

SourceCompuscript Ltd·JournalGenes & Diseases·DateJun 8, 2026

New fluorescent nanosensor enables rapid, first-of-its-kind detection of key gut health biomarker

Researchers developed a novel fluorescent nanosensor to detect IPA, an emerging biomarker linked to gut health and disease. The sensor offers rapid detection within minutes, distinguishing IPA from closely related metabolites, enabling accurate measurement even in complex biological environments.

SourceSingapore-MIT Alliance for Research and Technology (SMART)·JournalAdvanced Healthcare Materials·DateJun 2, 2026

Virtual-reality path integration for predicting risk of neurodegenerative diseases

Researchers found that impaired virtual reality path integration was closely tied to brain structure and biomarkers associated with neurodegeneration. This suggests that VR-based navigation errors may reveal hidden changes in the brain long before symptoms arise, making it a promising behavioral marker for preclinical Alzheimer's disease.

SourceFujita Health University·JournalAlzheimer s Research & Therapy·TypeObservational study·DateMay 27, 2026

International experts call for end to routine reporting of “corrected” calcium

International experts in laboratory medicine, osteoporosis, and chronic kidney disease recommend ending routine reporting of albumin-adjusted ('corrected') calcium. The practice may misclassify patients and compromise care due to unreliable correction formulas and variability in local measurements.

SourceInternational Osteoporosis Foundation·JournalClinical Chemistry and Laboratory Medicine (CCLM)·TypeCommentary/editorial·DateMay 18, 2026